IntelliGenome and NL Diagnóstica Partner to Advance Tuberculosis Detection in Brazil
Companies to showcase their collaboration at the UNION World Conference on Lung Health in Rio de Janeiro HOUSTON and SÃO PAULO, Nov. 2, 2026 /PRNewswire/ -- IntelliGenome, Inc., a developer of CRISPR-based molecular diagnostic technologies, today announced an exclusive distribution...
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


